Applicant, as named in the Orange Book

Ionis Pharms Inc

Next listed expiry: Tryngolza (Autoinjector) on 1 May 2034. 3 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Tryngolza (Autoinjector) · 2 strengths olezarsen sodium	olezarsen sodium	218614	1 May 2034	patent
Dawnzera (Autoinjector) donidalorsen sodium	donidalorsen sodium	219407	1 May 2035	patent
Zanvastro zilganersen sodium	zilganersen sodium	220210	20 May 2041	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.